RSV is a common respiratory virus that that can cause serious lung infections. While RSV infection can occur at any age, the risk and severity of RSV and its complications are increased in older adults and in neonates and small babies, and it has a considerable impact on individuals and NHS services during the winter months. The peak for RSV infections is November to February

The Joint Committee on Vaccination and Immunisation (JCVI) has recommended respiratory syncytial virus (RSV) vaccination programmes for older adults and during pregnancy for infant protection.

Routine cohort:

All patients turning 75 years old on or after 1 September 2024 will be eligible for a single dose of the RSV vaccine on or after their 75th birthday. In line with JCVI guidance, patients will remain eligible until the day before their 80th birthday.

GP VACCINATION PROGRAMME

1. 1. All patients turning 75 years old on or after 1 September 2024 will be offered a single dose of the RSV vaccine on or after their 75th birthday.
      Date of Birth range: 01 September 1945 to 31 August 1949: these individuals will remain eligible until the day before their 80th birthday.
      Date of Birth range: 02 September 1944 to 31 August 1945: these individuals will turn 80 in the first year of the programme and will remian eligible until 31 August 2025.